Immunologic enhancement of the somatogenic effect of somatotrophin with an antibody
CA 2042437 A1 · Owner: Hart, Ian C. · Inventors: Wang, Bosco S.; Hart, Ian C.; Lumanglas, Araceli L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
31,212-00, IMMUNOLOGIC ENHANCEMENT OF THE SOMATOGENIC EFFECT OF SOMATOTROPIN WITH AN ANTIBODY Abstract of the Disclosure, The present invention is directed to antibodies, in particular monoclonal antibodies of, porcine somatotropin (pST). When these antibodies are administered together with pST, the growth of vertebrates is greater than that achieved with the administration of pST alone. The invention is also directed to an increase in the growth of vertebrates which persists over long periods when an antibody to a somatotropin is administered together with such somatotropin.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 13, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 13, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 13, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.